CTRI/2013/12/004245已完成未知
Comparative efficacy, safety and pharmaco-economic evaluation of dressing with â??heparinoid preparationâ??, â??Magnesium Sulphate-glycerineâ?? and â??Ichthammol glycerineâ?? on phlebitis following peripheral intravenous cannulation: A double blinded randomized clinical trial,ACC, PGIMER, Chandigarh
Dr Sukhpal Kaur0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients admitted in ACC,PGIMER,Chandigarh and develop
- •phlebitis as the result of intravenous therapy.
- •Patients with visual infusion phlebitis score of two or more
- •Patients with infusion related phlebitis and not received any form of intervention by the staff
- •Patients who develop phlebitis only on the upper limbs.
排除标准
- •The patient/ legally acceptable representatives who are not willing to participate the study
- •- Patients who will be receiving chemotherapeutic agents
- •Patients with central venous catheter on the same limb.
- •Patients with dermatological disorders.
- •Patients with any bleeding disorders,injury to the same limb,pre-existing lymphatic obstruction.
- •Patients who are allergic to heparinoid or ichthammol glycerine or magsulph - glycerine
研究者
相似试验
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings - PRO.WIpatients with severe inherited VWD unresponsive to DDAVP and with frequent bleedingsMedDRA version: 8.1Level: PTClassification code 10047715Term: Von Willebrand's diseaseEUCTR2006-001383-23-ITFONDAZIONE CENTRO EMOFILIA E TROMBOSI ANGELO BIANCHI BONOMI24
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1 Level: PT Classification code 10047715 Term: Von Willebrand's disease System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2006-001383-23-GBProf Flora Peyvandi, MD24
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment ofsecondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWDand frequent bleedingsPatients with severe, inherited Von Willebrand’s disease and frequent bleedingsMedDRA version: 16.0Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2006-001383-23-DEFondazione IRCCS Cà Granda Ospedale Maggiore Policlinico24
进行中（未招募）
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2006-001383-23-ESFondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico24
尚未招募
Unknown
Effectiveness of montelukast plus bilastine vs montelukast plus levocetirizine in allergic rhinitis.CTRI/2024/08/071971Dr Ganesh Dakhale